331950-32-4

Basic information

• Product Name: 2-amino-4-(3-bromophenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile
• Synonyms: 2-Amino-4-(3-bromophenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile; 2-Amino-4-(3-bromphenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitril; 4H,5H-Pyrano[4,3-b]pyran-3-carbonitrile, 2-amino-4-(3-bromophenyl)-7-methyl-5-oxo-
• CAS NO: 331950-32-4
• Molecular Formula: C₁₆H₁₁BrN₂O₃
• Molecular Weight: 359.1741
• Mol File: 331950-32-4.mol

Chemical Properties

• Boiling Point: 608.6°C at 760 mmHg
• Flash Point: 321.9°C
• Density: 1.66g/cm³
• Vapor Pressure: 9.38E-15mmHg at 25°C
• Refractive Index: 1.688
• PKA: 2.92±0.60(Predicted)
• CAS DataBase Reference: 2-amino-4-(3-bromophenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-4-(3-bromophenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile(331950-32-4)
• EPA Substance Registry System: 2-amino-4-(3-bromophenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile(331950-32-4)

Safety Data

• Hazardous Substances Data: 331950-32-4(Hazardous Substances Data)

Upstream product

• 675-10-5 4-hydroxy-6-methyl-2-pyron 
• 3132-99-8 m-bromobenzoic aldehyde 
• 109-77-3 malononitrile 

Relevant articles and documents

Tertiary amine-bisquaternary ammonium functionalized polyacrylonitrile fiber for catalytic synthesis of pyran-annulated heterocycles

Polyacrylonitrile fiber supported bisquaternary ammonium salts with varying interchain quaternary ammonium (QA) to tertiary amine (TA) ratio, counter ions and linker groups were prepared and characterized by TGA, FTIR, XPS, XRD, SEM, EA and water contact

1H-imidazol-3-ium tricyanomethanide {[HIM]C(CN)3} as a nanostructured molten salt catalyst: application to the synthesis of pyrano[4,3‐b]pyrans

In this work, we have synthesized a novel nanostructured molten salt, 1H-imidazol-3-ium tricyanomethanide {[HIMI]C(CN)3} (1), as an efficient and green protocol-compatible catalyst. This new molten salt has been fully characterized b

4-(Succinimido)-1-butane sulfonic acid as a Br?nsted acid catalyst for the synthesis of pyrano[4,3-b]pyran derivatives using thermal and ultrasonic irradiation

4-(Succinimido)-1-butane sulfonic acid was shown to be an efficient and reusable Br?nsted acid catalyst for the synthesis of pyrano[4,3-b]pyran derivatives using thermal and ultrasonic conditions. The catalyst was prepared by mixing succinimide and 1,4-bu

4-(Succinimido)-1-butane sulfonic acid as a br?nsted acid catalyst for synthesis of pyrano[4,3-b]pyran derivatives under solvent-free conditions

4-(Succinimido)-1-butane sulfonic acid as an efficient and reusable Br?nsted acid catalyzed the synthesis of pyrano[4,3-b]pyran derivatives under solvent-free conditions. The catalyst can be prepared by mixing succinimide and 1,4-butanesultone that is mor

Nickel nanoparticles as semiheterogeneous catalyst for one-pot, three-component synthesis of 2-amino-4H-pyrans and pyran annulated heterocyclic moieties

An efficient route for the synthesis of 2-amino-4H-pyrans and pyran annulated heterocyclic moieties has been reported via one-pot tandem Knoevenagel-cyclocondensation of aldehydes, malononitrile, and carbocyclic/heterocyclic 1,3-diones in the presence of

Pyrano [3,2-C] Pyridones and Related Heterocyclic Compounds as Pharmaceutical Agents for Treating Disorders Responsive to Apoptosis, Antiproliferation or Vascular Disruption, and the Use Thereof

A pharmaceutical composition comprising a pharmaceutically acceptable excipient or carrier and a compound Formula I: or a pharmaceutically acceptable salt or prodrug thereof.